Fully-Integrated Vendor Management Support in Phase 2

VRMM Stage: Optimization
Seuss+ supported a high-potential biotech entering Phase 2 with an ambitious formulation study, when late strategic changes made its original CRO unsuitable. With a lean team under competitive pressure, we ran a rapid CRO transition and took on complete vendor oversight and embedded support.

Summary

A high-potential biotech, entering Phase 2 with an ambitious formulation study, faced late-stage strategic changes that rendered its original CRO unsuitable.

Operating with a lean team and under competitive pressures, the sponsor required rapid CRO transition, complete vendor oversight, and embedded operational expertise to stay on schedule and protect data integrity.

anaveon image 3

New CRO contract savings

vendor alignment achieved

through enforced RACI + governance

14
years of hands-on vendor optimization
Seuss+
55+
biotech programs supported
Seuss+
10+
therapeutic areas of expertise
Seuss+

What Seuss+ Delivered

Embedded Vendor Management & CRO Transition

Seuss+ provided fully integrated support, embedding a senior subject matter expert within the sponsor’s team. Drawing on VRMM methodology, we combined operational oversight, risk governance, and financial control to manage settlement negotiations, expedite a new CRO selection, and ensure full vendor alignment.

 

The Risk/Challenge

M

Original CRO no longer suitable due to a shift in strategic direction

M

Need to manage sensitive contract settlements to protect the sponsor reputation

M

Limited internal capacity to manage vendor transitions and multiple workstreams

M

Risk of data integrity loss due to oversight gaps between vendors

M

Tight timelines in a competitive therapeutic landscape

The Results

N

CRO settlement saving: $858K

N

Site network saving: $50K

N

Service provider savings: 3% discount achieved

N

New CRO contract savings: more than $2M (in finalization)

N

Full vendor alignment achieved; data integrity risk mitigated through enforced RACI and cross-vendor governance

N

Sponsor team maintained focus on trial strategy while Seuss+ managed operational complexity

Timeline

2025 clinical trial project timeline spanning Feb–Jan 26, showing CRO selection, vendor management, governance, risk

How We Helped

Negotiated settlement with the original CRO, protecting sponsor reputation and freeing the team to focus on strategic priorities

Designed and executed a new CRO selection process within 7.5 weeks, from RFP design to bid defense and final selection

Centralized vendor oversight and contract negotiations, eliminating overlapping service costs

Embedded a Seuss+ SME in the sponsor’s team for continuous operational coordination

Implemented RACI and oversight protocols to prevent data integrity risk between vendors

Frequently asked questions

Late-stage strategic changes rendered the original CRO unsuitable, and staying would have risked the Phase 2 program.

We ran a rapid CRO transition, took on complete vendor oversight, and embedded support so the lean internal team was not overwhelmed.

We own the coordination across every vendor, selection, contracts, risk, and oversight, as one accountable system.

Schedule a consultation now

 

Key takeaways

  • The challenge: late strategic changes made the original CRO unsuitable heading into Phase 2, with a lean team and competitive pressure.
  • Seuss+ ran a rapid CRO transition with full vendor oversight and embedded support.
  • The work spanned selection, contracting, risk, and oversight (VRMM optimization stage).

Talk to the Seuss+ team

Book a 30-minute strategic call to see how this fits your trial.

Book an intro call